Radiation Therapy Followed by Intrathecal Trastuzumab-Pertuzumab for ERBB2-Positive Breast Leptomeningeal Disease: A Phase 1 Nonrandomized Controlled Trial.
JAMA Oncol
; 10(7): 984-986, 2024 Jul 01.
Article
en En
| MEDLINE
| ID: mdl-38780965
This nonrandomized controlled trial examines the safety of radiation therapy (RT) followed by intrathecal trastuzumab and pertuzumab for patients with ERBB2-positive breast leptomeningeal disease (LMD).
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Inyecciones Espinales
/
Neoplasias de la Mama
/
Receptor ErbB-2
/
Anticuerpos Monoclonales Humanizados
/
Trastuzumab
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
JAMA Oncol
Año:
2024
Tipo del documento:
Article
Pais de publicación:
Estados Unidos